Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion

We have compared the molecular specificities of the adhesive interactions of melanoma and fibroblastic cells with fibronectin. Several striking differences were found in the sensitivity of the two cell types to inhibition by a series of synthetic peptides modeled on the Arg-Gly-Asp-Ser (RGDS) tetrapeptide adhesion signal. Further evidence for differences between the melanoma and fibroblastic cell adhesion systems was obtained by examining adhesion to proteolytic fragments of fibronectin. Fibroblastic BHK cells spread readily on fl3, a 75-kD fragment representing the RGDS-containing, "cell-binding" domain of fibronectin, but B16-F10 melanoma cells could not. The melanoma cells were able to spread instead on f9, a 113-kD fragment derived from the large subunit of fibronectin that contains at least part of the type III connecting segment difference region (or "V" region); f7, a fragment from the small fibronectin subunit that lacks this alternatively spliced polypeptide was inactive. Monoclonal antibody and fl3 inhibition experiments confirmed the inability of the melanoma cells to use the RGDS sequence; neither molecule affected melanoma cell spreading, but both completely abrogated fibroblast adhesion. By systematic analysis of a series of six overlapping synthetic peptides spanning the entire type III connecting segment, a novel attachment site was identified in a peptide near the COOH- terminus of this region. The tetrapeptide sequence Arg-Glu-Asp-Val (REDV), which is somewhat related to RGDS, was present in this peptide in a highly hydrophilic region of the type III connecting segment. REDV appeared to be functionally important, since this synthetic tetrapeptide was inhibitory for melanoma cell adhesion to fibronectin but was inactive for fibroblastic cell adhesion. REDV therefore represents a novel adhesive recognition signal in fibronectin that possesses cell type specificity. These results suggest that, for some cell types, regulation of the adhesion-promoting activity of fibronectin may occur by alternative mRNA splicing.

[1]  A. Vaheri,et al.  Fibronectin in formation and degradation of the pericellular matrix. , 1985, Ciba Foundation symposium.

[2]  K. Yamada,et al.  Fibronectin in disease. , 1983, Monographs in pathology.

[3]  P. McKeown-Longo,et al.  Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts , 1985, The Journal of cell biology.

[4]  T J Poole,et al.  Biologically active synthetic peptides as probes of embryonic development: a competitive peptide inhibitor of fibronectin function inhibits gastrulation in amphibian embryos and neural crest cell migration in avian embryos , 1984, The Journal of cell biology.

[5]  E Ruoslahti,et al.  Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Hynes,et al.  Three different fibronectin mRNAs arise by alternative splicing within the coding region , 1983, Cell.

[7]  A. Woods,et al.  Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. , 1986, The EMBO journal.

[8]  Kenneth M. Yamada,et al.  Peptide inhibitors of fibronectin, laminin, and other adhesion molecules: Unique and shared features , 1987, Journal of cellular physiology.

[9]  E. Ruoslahti,et al.  Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. , 1985, The Journal of biological chemistry.

[10]  A. Kornblihtt,et al.  Isolation and characterization of cDNA clones for human liver fibronectin , 1985, FEBS letters.

[11]  H. Kleinman,et al.  Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Spiegel,et al.  Fibrillar organization of fibronectin is expressed coordinately with cell surface gangliosides in a variant murine fibroblast , 1986, The Journal of cell biology.

[13]  R. Hynes,et al.  Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Ruoslahti,et al.  Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.

[15]  A. Kornblihtt,et al.  Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. , 1984, Nucleic acids research.

[16]  E Ruoslahti,et al.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Humphries,et al.  Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Ruoslahti,et al.  Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor , 1985, Cell.

[19]  C. Buck,et al.  The cell substrate attachment (CSAT) antigen has properties of a receptor for laminin and fibronectin , 1985, The Journal of cell biology.

[20]  R. Beyth,et al.  Complementary adhesive responses of human skin fibroblasts to the cell-binding domain of fibronectin and the heparan sulfate-binding protein, platelet factor-4. , 1984, Experimental cell research.

[21]  R. Hynes,et al.  A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Humphries,et al.  A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. , 1986, Science.

[23]  R. Hynes,et al.  Cell-type-specific fibronectin subunits generated by alternative splicing. , 1986, The Journal of biological chemistry.

[24]  F. Grinnell,et al.  Adsorption characteristics of plasma fibronectin in relationship to biological activity. , 1981, Journal of biomedical materials research.

[25]  A. Schechter,et al.  Tritium labeling of proteins to high specific radioactivity by reduction methylation. , 1980, The Journal of biological chemistry.

[26]  I. Fidler Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. , 1974, Cancer research.

[27]  S. Spiegel,et al.  Fluorescent gangliosides as probes for the retention and organization of fibronectin by ganglioside-deficient mouse cells , 1985, The Journal of cell biology.

[28]  L. Zardi,et al.  Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains. , 1985, European journal of biochemistry.

[29]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[30]  R. Hynes,et al.  On the origin of species of fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Yamada,et al.  Characterization of a 140-kD avian cell surface antigen as a fibronectin-binding molecule , 1986, The Journal of cell biology.

[32]  Akiyama Sk,et al.  Fibronectin in disease. , 1983, Monographs in pathology.

[33]  K M Yamada,et al.  Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.

[34]  K. Yamada,et al.  The interaction of plasma fibronectin with fibroblastic cells in suspension. , 1985, The Journal of biological chemistry.

[35]  Robert L. Trelstad,et al.  The Role of extracellular matrix in development , 1984 .

[36]  B. Frangione,et al.  Primary structure of human plasma fibronectin. Characterization of a 31,000-dalton fragment from the COOH-terminal region containing a free sulfhydryl group and a fibrin-binding site. , 1985, The Journal of biological chemistry.

[37]  K. Yamada,et al.  Amino acid sequence specificities of an adhesive recognition signal , 1985, Journal of cellular biochemistry.

[38]  R. Hynes,et al.  Molecular biology of fibronectin. , 1985, Annual review of cell biology.

[39]  K. Yamada,et al.  Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function , 1984, The Journal of cell biology.

[40]  A. Reddi,et al.  Extracellular matrix: Structure and function , 2022 .

[41]  K. Yamada,et al.  The interaction of fibronectin fragments with fibroblastic cells. , 1985, The Journal of biological chemistry.

[42]  T. Wieland,et al.  Symmetrical Boc-amino acid anhydrides for economical peptide syntheses on a solid phase. , 1971, Angewandte Chemie.

[43]  R. B. Merrifield Solid phase peptide synthesis. I. the synthesis of a tetrapeptide , 1963 .

[44]  R. Hynes,et al.  Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin , 1986, Cell.

[45]  J. Moss,et al.  Exogenous gangliosides enhance the interaction of fibronectin with ganglioside-deficient cells. , 1983, Experimental cell research.

[46]  D. Weil,et al.  Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions. , 1985, Biochemistry.

[47]  K. Ingham,et al.  Rapid methods for isolation of human plasma fibronectin. , 1982, Thrombosis research.

[48]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[49]  D. Mosher Physiology of fibronectin. , 1984, Annual review of medicine.

[50]  J. McCarthy,et al.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells , 1986, The Journal of cell biology.

[51]  K. R. Woods,et al.  Prediction of protein antigenic determinants from amino acid sequences. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Bentley,et al.  Localization of the ganglioside-binding site of fibronectin. , 1986, The Journal of biological chemistry.

[53]  F. Grinnell Fibronectin and wound healing. , 1982, The American Journal of dermatopathology.

[54]  A. Kornblihtt,et al.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. , 1985, The EMBO journal.

[55]  E. Ruoslahti,et al.  Synthetic peptide with cell attachment activity of fibronectin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Kenneth M. Yamada,et al.  Characterization of a membrane‐associated glycoprotein complex implicated in cell adhesion to fibronectin , 1985, Journal of cellular biochemistry.

[57]  K. Yamada,et al.  Domain structure of the carboxyl-terminal half of human plasma fibronectin. , 1983, The Journal of biological chemistry.

[58]  A new synthetic route to tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an improved support for solid-phase peptide synthesis , 1978 .

[59]  S. Santoro,et al.  Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin. , 1985, Blood.

[60]  K. Yamada,et al.  Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin. , 1985, The Journal of biological chemistry.

[61]  Gary R. Grotendorst,et al.  Glycolipids: Receptors for fibronectin? , 1981, Journal of cellular physiology.